House Passes Chronic Disease Flexibility Act To Expand Coverage Under High-Deductible Health Plans

New legislation advanced by a voice vote March 4 would codify 14 pre-deductible healthcare services through high-deductible health plans (HDHPs). It codifies guidance from President Donald Trump’s first term increasing flexible coverage options for HDHPs. The bill would allow medical products and services like beta-blockers, blood pressure monitors, glucometers, inhalers and cholesterol drugs to be ...

Read More

Musk Eyes Social Security And Benefit Programs For Cuts While Claiming Widespread Fraud

Elon Musk pushed debunked theories about Social Security on Monday while describing federal benefit programs as rife with fraud, suggesting they will be a primary target in his crusade to reduce government spending. The billionaire entrepreneur, who is advising President Donald Trump, suggested that $500 billion to $700 billion in waste needed to be cut. “Most of the federal ...

Read More

More Hospitals Are Treating Patients At Home To Reduce Overcrowding. Here’s How It Works.

For James Edwards, a 57-year-old patient with congestive heart failure, recovering at home from shortness of breath rather than in a hospital setting was a welcome option. Nurses come to check on him twice a day and monitoring equipment would notify the hospital about any change in vitals. The house calls are part of a ...

Read More

RFK Jr. Awkward Face-To-Face With Food Companies

Robert F. Kennedy Jr. is planning to meet with top executives of several major food brands on Monday, marking the first sitdown between the new Health and Human Services secretary and companies he’s publicly accused of harming Americans’ health. Senior leaders from General Mills and PepsiCo are among those expected to participate in the discussion ...

Read More

Walgreens to Be Bought by Private Equity Firm in $10 Billion Deal

Shares of Walgreens Boots Alliance have lost about half their value in the past year, as the chain has faced pressure in its retail and pharmacy businesses.

Read More

HHS Employees Offered $25K Voluntary Buyout Offer—But Not All FDA Workers

Editor’s Note: This is a developing story. If you are a dismissed or active federal worker with information to share, please reach out at ntong@questex.com Updated: Monday, March 10 at 5:07 p.m. ET Health and Human Services (HHS) Department employees, which totals about 80,000, were offered voluntary buyouts to resign from their jobs Friday night. The agency’s employees ...

Read More

Lawmakers Hear Worst-Case Scenarios: Medicaid Cuts In Nevada

Last week, Nevada state lawmakers heard worst case scenarios if Congress significantly reduces federal Medicaid spending. There’s a lot of uncertainty as state lawmakers are required to pass the biennial budget over the next 100 days. One in four Nevadans is insured by Medicaid, the health care insurance program for low-income and disabled Americans. In Nevada, ...

Read More

Trump Vowed To End Surprise Medical Bills. The Office Working on That Just Got Slashed.

As President Donald Trump wrapped up his first term in 2020, he signed legislation to protect Americans from surprise medical bills. “This must end,” Trump said. “We’re going to hold insurance companies and hospitals totally accountable.” But the president’s wide-ranging push to slash government spending, led by billionaire Elon Musk, is weakening the federal office ...

Read More

Hundreds Of Stakeholders Urge Congress To Make HSA Telehealth Provision Permanent

More than 8 in 10 employers intend to offer employees and their dependents access to lower- or no-cost mental health support through their tele-mental health provider this year, the letter said.

Read More

Pfizer Could Shift Overseas Production To U.S. If Trump’s Pharma Tariffs Take Hold, CEO Says

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert Bourla, Ph.D., outlined one potential response by his company if pharmaceutical tariffs come into play. Pfizer’s local manufacturing setup is already well positioned in the U.S., and the New York-based drugmaker could bring additional resources into ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square